Literature DB >> 12145775

An LMNA variant is associated with dyslipidemia and insulin resistance in the Japanese.

Yuko Murase1, Kunimasa Yagi, Yuko Katsuda, Akimichi Asano, Junji Koizumi, Hiroshi Mabuchi.   

Abstract

Nuclear lamins A and C are encoded by LMNA and are present in terminally differentiated cells. Rare mutations in LMNA were shown to cause familial partial lipodystrophy, a syndrome characterized by regional loss of adipose tissue, glucose intolerance, and dyslipidemia, making LMNA a candidate gene for insulin-resistant diabetes. The aim of this study was to investigate whether genetic variation in LMNA can influence the risk of type 2 diabetes in a Japanese cohort. First, we performed mutational screening of LMNA by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) and sequence analysis in 8 insulin-resistant males with acanthosis nigricans who were not lipodystrophic. One known single nucleotide polymorphism, 1908C/T, was found in exon 10. We subsequently screened samples of 171 nondiabetic and 164 type 2 diabetic male subjects for the presence of the 1908C/T polymorphism by PCR-restriction fragment length polymorphism (RFLP). The frequency of subjects with the 1908T allele tended to be higher in the diabetic group than in the nondiabetic group; however, the difference was not significant (43.9% v 32.2%) (P =.084). Carriers of the 1908T allele, both among diabetics and nondiabetics, showed significantly higher fasting insulin, triglycerides (TG), total cholesterol (TC), and lower high-density lipoprotein-cholesterol (HDL-C) levels than those of the 1908C/C subjects. These results suggest the LMNA 1908C/T single nucleotide polymorphism (SNP) is not associated with the prevalence of type 2 diabetes, although it may be a factor predisposing to insulin resistance and dyslipidemia in some Japanese. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145775     DOI: 10.1053/meta.2002.34030

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  Diseases of the nuclear envelope.

Authors:  Howard J Worman; Cecilia Ostlund; Yuexia Wang
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

2.  Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Authors:  Benedicte Fontaine-Bisson; Marie-Christine Alessi; Noemie Saut; Frederic Fumeron; Michel Marre; Anne Dutour; Catherine Badens; Nicolas Levy; Jean Tichet; Irene Juhan-Vague; David-Alexandre Trégouët; Beverly Balkau; Pierre-Emmanuel Morange
Journal:  J Mol Med (Berl)       Date:  2009-10-16       Impact factor: 4.599

3.  Lamin A/C polymorphisms, type 2 diabetes, and the metabolic syndrome: case-control and quantitative trait studies.

Authors:  José L Mesa; Ruth J F Loos; Paul W Franks; Ken K Ong; Jian'an Luan; Stephen O'Rahilly; Nicholas J Wareham; Inês Barroso
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

4.  Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes: association analyses in 9,518 subjects.

Authors:  Katharine R Owen; Christopher J Groves; Robert L Hanson; William C Knowler; Alan R Shuldiner; Steven C Elbein; Braxton D Mitchell; Philippe Froguel; Maggie C Y Ng; Juliana C Chan; Weiping Jia; Panos Deloukas; Graham A Hitman; Mark Walker; Timothy M Frayling; Andrew T Hattersley; Eleftheria Zeggini; Mark I McCarthy
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

Review 5.  Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.

Authors:  Alex Zhavoronkov; Zeljka Smit-McBride; Kieran J Guinan; Maria Litovchenko; Alexey Moskalev
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.